Palliative treatment of oesophageal cancer with dysphagia: More favourable outcome from single-dose internal brachytherapy than from the placement of a self-expanding stent; a multicentre randomised study;Palliatieve behandeling voor slokdarmkanker met passageklachten: Gunstiger uitkomsten van eenmalige inwendige brachytherapie dan van plaatsing van een zelfexpanderende stent; multicentrisch, gerandomiseerd onderzoek

Nederlands Tijdschrift voor Geneeskunde

Volumn 149, Issue 50, 2005, Pages 2800-2806

  Homs, M Y V ^a   Steyerberg, E W ^a   Eijkenboom, W M H ^a   Tilanus, H W ^a   Stalpers, L J A ^b   Bartelsman, J F W M ^b   Van Lanschot, J J B ^b   Wijrdeman, H K ^c   Mulder, C J J ^d   Reinders, J G ^e   Boot, H ^f   Aleman, B M P ^f   Kuipers, E J ^a   Siersema, P D ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d RIJNSTATE HOSPITAL   (Netherlands)

^e Arnhems Radiotherapeutisch Instituut   (Netherlands)

^f ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CONTROLLED STUDY; DYSPHAGIA; ESOPHAGUS CARCINOMA; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; QUALITY OF LIFE; RECURRENT DISEASE; SURVIVAL;

AGED; BRACHYTHERAPY; DEGLUTITION DISORDERS; ESOPHAGEAL NEOPLASMS; ESOPHAGEAL STENOSIS; FEMALE; HUMANS; MALE; METALS; PALLIATIVE CARE; QUALITY OF LIFE; RECURRENCE; STENTS;

EID: 29144480319     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer. 2001;37(Suppl 8):S4-66.
2. Botterweck AA, Schouten LJ, Volovics A, Dorant E, Brandt PA van den. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol. 2000;29:645-54.
3. Devesa SS, Blot WJ, Fraumeni jr JF. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 1998;83:2049-53.
4. Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer. 1999;83:18-29.
5. Sundelof M, Ye W, Dickman PW, Lagergren J. Improved survival in both histologic types of oesophageal cancer in Sweden. Int J Cancer. 2002;99:751-4.
6. De Palma GD, Galloro G, Sivero L, di Matteo E, Labianca O, Siciliano S, et al. Self-expanding metal stents for palliation of inoperable carcinoma of the esophagus and gastroesophageal junction. Am J Gastroenterol. 1995;90:2140-2.
7. Siersema PD, Hop WC, Blankenstein M van, Tilburg AJ van, Bac DJ, Horns MY, et al. A comparison of 3 types of covered metal stents for the palliation of patients with dysphagia caused by esophagogastric carcinoma: a prospective, randomized study. Gastrointest Endosc. 2001;5:145-53.
8. Kozarek RA, Raltz S, Brugge WR, Schapiro RH, Waxman I, Boyce HW, et al. Prospective multicenter trial of esophageal Z-stent placement for malignant dysphagia and tracheoesophageal fistula. Gastrointest Endosc. 1996;44:562-7.
9. Raijman I, Siddique I, Ajani J, Lynch P. Palliation of malignant dysphagia and fistulae with coated expandable metal stents: experience with 101 patients. Gastrointest Endosc. 1998;48:172-9.
10. Bartelsman JF, Bruno MJ, Jensema AJ, Haringsma J, Reeders JW, Tytgat GN. Palliation of patients with esophagogastric neoplasms by insertion of a covered expandable modified Gianturco-Z endoprosthesis: experiences in 153 patients. Gastrointest Endosc. 2000;51:134-8.
11. Spencer GM, Thorpe SM, Blackman GM, Solano J, Tobias JS, Lovat LB, et al. Laser augmented by brachytherapy versus laser alone in the palliation of adenocarcinoma of the oesophagus and cardia: a randomised study. Gut. 2002;50:224-7.
12. Dallal HJ, Smith GD, Grieve DC, Ghosh S, Penman ID, Palmer KR. A randomized trial of thermal ablative therapy versus expandable metal stents in the palliative treatment of patients with esophageal carcinoma. Gastrointest Endosc. 2001;54:549-57.
13. Taal BG, Aleman BM, Koning CC, Boot H. High dose rate brachytherapy before external beam irradiation in inoperable oesophageal cancer. Br J Cancer. 1996;74:1452-7.
14. Schraube P, Fritz P, Wannenmacher MF. Combined endoluminal and external irradiation of inoperable oesophageal carcinoma. Radiother Oncol. 1997;44:45-51.
15. Homs MYV, Eijkenboom WM, Coen VL, Haringsma J, Blankenstein M van, Kuipers EJ, et al. High dose rate brachytherapy for the palliation of malignant dysphagia. Radiother Oncol. 2003;66:327-32.
16. Brewster AE, Davidson SE, Makin WP, Stout R, Burt PA. Intraluminal brachytherapy using the high dose rate microSelectron in the palliation of carcinoma of the oesophagus. Clin Oncol (R Coll Radiol). 1995;7:102-5.
17. Gaspar LE, Nag S, Herskovic A, Mantravadi R, Speiser B. American Brachytherapy Society (ABS) consensus guidelines for brachytherapy of esophageal cancer. Clinical Research Committee, American Brachytherapy Society, Philadelphia, PA. Int J Radiat Oncol Biol Phys. 1997;38:127-32.
18. Sur RK, Levin CV, Donde B, Sharma V, Miszczyk L, Nag S. Prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma - an International Atomic Energy Agency study. Int J Radiat Oncol Biol Phys. 2002;53:127-33.
19. Allum WH, Griffin SM, Watson A, Colin-Jones D. Guidelines for the management of oesophageal and gastric cancer. Gut. 2002;50 (Suppl 5):VI-23.
20. Blazeby JM. Measurement of outcome. Surg Oncol. 2001;10:127-33.
21. Ogilvie AL, Dronfield MW, Ferguson R, Atkinson M. Palliative intubation of oesophagogastric neoplasms at fibreoptic endoscopy. Gut. 1982;23:1060-7.
22. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365-76.
23. Blazeby JM, Alderson D, Winstone K, Steyn R, Hammerlid E, Arraras J, et al. Development of an EORTC questionnaire module to be used in quality of life assessment for patients with oesophageal cancer. The EORTC Quality of Life Study Group. Eur J Cancer. 1996;32A:1912-7.
24. Dolan P. Modeling valuations for EuroQol health states. Med Care. 1997;35:1095-108.
25. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996.
26. Jager J, Langendijk H, Pannebakker M, Rijken J, Jong J de. A single session of intraluminal brachytherapy in palliation of oesophageal cancer. Radiother Oncol. 1995;37:237-40.
27. Sur RK, Donde B, Levin VC, Mannell A. Fractionated high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer. Int J Radiat Oncol Biol Phys. 1998;40:447-53.
28. Harrell jr FE, Lee KL, Pollock BG. Regression models in clinical studies: determining relationships between predictors and response. J Natl Cancer Inst. 1988;80:1198-202.
29. Fairclough DL. Design and analysis of quality of life studies in clinical trials. Boca Raton: Chapman & Hall; 2002.
30. Thompson SG, Barber JA. How should cost data in pragmatic randomised trials be analysed? BMJ. 2000;320:1197-200.
31. Siersema PD, Tan TG, Sutorius FF, Dees J, Blankenstein M van. Massive hemorrhage caused by a perforating Gianturco-Z stent resulting in an aortoesophageal fistula. Endoscopy. 1997;29:416-20.
32. Allgaier HP, Schwacha H, Technau K, Blum HE. Fatal esophagoaortic fistula after placement of a self-expanding metal stent in a patient with esophageal carcinoma. N Engl J Med. 1997;337:1778.
33. Sur M, Sur R, Cooper K, Levin V, Bizos D, Dubazana N. Morphologic alterations in esophageal squamous cell carcinoma after preoperative high dose rate intraluminal brachytherapy. Cancer. 1996;77:2200-5.
34. Siersema PD, Marcon N, Vakil N. Metal stents for tumors of the distal esophagus and gastric cardia. Endoscopy. 2003;35:79-85.
35. Sabharwal T, Hamady MS, Chui S, Atkinson S, Mason R, Adam A. A randomised prospective comparison of the Flamingo Wallstent and Ultraflex stent for palliation of dysphagia associated with lower third oesophageal carcinoma. Gut. 2003;52:922-6.
36. Christie NA, Buenaventura PO, Fernando HC, Nguyen NT, Weigel TL, Ferson PF, et al. Results of expandable metal stents for malignant esophageal obstruction in 100 patients: short-term and long-term follow-up. Ann Thorac Surg. 2001;71:1797-801.
37. Vakil N, Morris AI, Marcon N, Segalin A, Peracchia A, Bethge N, et al. A prospective, randomized, controlled trial of covered expandable metal stents in the palliation of malignant esophageal obstruction at the gastroesophageal junction. Am J Gastroenterol. 2001;96:1791-6.